Banque Cantonale Vaudoise Moderna, Inc. Transaction History
Banque Cantonale Vaudoise
- $2.43 Billion
- Q3 2024
A detailed history of Banque Cantonale Vaudoise transactions in Moderna, Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 19,812 shares of MRNA stock, worth $724,128. This represents 0.05% of its overall portfolio holdings.
Number of Shares
19,812
Previous 29,130
31.99%
Holding current value
$724,128
Previous $3.46 Million
61.78%
% of portfolio
0.05%
Previous 0.14%
Shares
19 transactions
Others Institutions Holding MRNA
# of Institutions
914Shares Held
236MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.47 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.42 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$934 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$616 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$264 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $14.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...